Sign in to view content

Progression of diabetic retinopathy in patients treated with 0.2 μg/day

Raymond Iezzi, MD, MS

Video
Published 2017

Related

36-Month Outcomes of Injectable Fluocinolone Acetonide Intravitreal Insert on Recurrences of Non-infectious Posterior Segment Uveitis
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2019
Treat-and-Extend Versus Bimonthly Dosing With Aflibercept for the Treatment of Diabetic Macular Edema, 1-Year Outcomes (EVADE Study)
Dilsher S. Dhoot, MD
Annual Meeting Talks
2018
Long-term Anti-VEGF Treatment Following Vitrectomy for Endophthalmitis in Patients With Neovascular AMD
Zofia Anna Nawrocka (vel Michalewska), MD, PhD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more